<DOC>
	<DOCNO>NCT00247650</DOCNO>
	<brief_summary>This study measure extent tumor shrinkage Letrozole Zoledronic Acid give surgery newly diagnose post-menopausal woman early breast cancer</brief_summary>
	<brief_title>Comparison Study Letrozole Alone Letrozole With Zoledronic Acid Early Breast Cancer , Neoadjuvant Therapy</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Zoledronic acid</mesh_term>
	<mesh_term>Diphosphonates</mesh_term>
	<mesh_term>Letrozole</mesh_term>
	<criteria>Inclusion Criteria Postmenopausal woman Newly diagnose non metastatic breast cancer Candidate mastectomy breastconserving surgery Exclusion Criteria Patients invasive tumor Patients receive anticancer treatment Patients undergone surgery Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>Female</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>neoadjuvant , postmenopausal woman , breast cancer , hormonal therapy , bisphosphonate</keyword>
</DOC>